RELMADA THERAPEUTICS, INC. Line of Credit Facility, Increase (Decrease), Net
RELMADA THERAPEUTICS, INC. (RLMD) reported Line of Credit Facility, Increase (Decrease), Net of $234.40 thousand for the 9-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Notes › Debt
us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet · last filed 2017-05-15
- RELMADA THERAPEUTICS, INC. line of credit facility, increase (decrease), net for the quarter ending 2017-03-31 was $0.00.
- RELMADA THERAPEUTICS, INC. line of credit facility, increase (decrease), net for the quarter ending 2016-12-31 was $0.00.
- RELMADA THERAPEUTICS, INC. line of credit facility, increase (decrease), net for the quarter ending 2016-09-30 was $234.40K.
| Period end | Line of Credit Facility, Increase (Decrease), Net 3 month | Line of Credit Facility, Increase (Decrease), Net 6 month | Line of Credit Facility, Increase (Decrease), Net 9 month |
|---|---|---|---|
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | $0.00 derived: sum of 2 quarters · filed 2017-05-15 | $234.40K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | $234.40K 10-Q · filed 2017-02-10 | |
| 2016-09-30 | $234.40K 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |